Trial comparisons

Response

The first 2 of this page's 20 results. GET /api/comparisons/v1?page=22

{
  "data": {
    "total": 85013,
    "results": [
      {
        "id": "NCT02446990-80aaf197-4",
        "title": "Ivabradine vs Placebo: Secondary Composite Endpoint",
        "summary": "774 of 9550 against 731 of 9552; risk difference 0.5 points, 95% interval -0.3 to 1.2; NCT02446990, Effects of Ivabradine in Patients With Stable Coronary Artery Disease Without Clinical Heart Failure",
        "record": "/library/comparisons/NCT02446990-80aaf197-4",
        "nct_id": "NCT02446990",
        "kind": "outcome",
        "participants": 19102,
        "risk_difference": {
          "value": 0.0045186447069553715,
          "lower": -0.0031261380490274077,
          "upper": 0.012167204415471887
        },
        "group_1": "774 of 9,550",
        "group_2": "731 of 9,552",
        "difference": "0.5 points",
        "interval": "-0.3 to 1.2",
        "trial_title": "Effects of Ivabradine in Patients With Stable Coronary Artery Disease Without Clinical Heart Failure"
      },
      {
        "id": "NCT02446990-80aaf197-5",
        "title": "Ivabradine vs Placebo: Secondary Composite Endpoint",
        "summary": "590 of 9550 against 562 of 9552; risk difference 0.3 points, 95% interval -0.4 to 1.0; NCT02446990, Effects of Ivabradine in Patients With Stable Coronary Artery Disease Without Clinical Heart Failure",
        "record": "/library/comparisons/NCT02446990-80aaf197-5",
        "nct_id": "NCT02446990",
        "kind": "outcome",
        "participants": 19102,
        "risk_difference": {
          "value": 0.002944258815894482,
          "lower": -0.003813251597770898,
          "upper": 0.009705872335266489
        },
        "group_1": "590 of 9,550",
        "group_2": "562 of 9,552",
        "difference": "0.3 points",
        "interval": "-0.4 to 1.0",
        "trial_title": "Effects of Ivabradine in Patients With Stable Coronary Artery Disease Without Clinical Heart Failure"
      }
    ],
    "no_events": 33758,
    "columns": [
      {
        "key": "title",
        "label": "Comparison"
      },
      {
        "key": "group_1",
        "label": "With the outcome",
        "under": "group_2"
      },
      {
        "key": "difference",
        "label": "Risk difference, 95% interval",
        "under": "interval"
      },
      {
        "key": "participants",
        "label": "Participants"
      },
      {
        "key": "nct_id",
        "label": "Trial",
        "under": "trial_title"
      }
    ],
    "order": "Most participants first",
    "kinds": {
      "all": 85013,
      "outcome": 33568,
      "serious-adverse-events": 31897,
      "deaths": 19548
    }
  },
  "release": "trial-comparisons-2026-03-23-0.1.0",
  "terms": [
    {
      "source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
      "license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "Freely available. Acknowledgement requested"
    },
    {
      "source": "ClinicalTrials.gov",
      "license": "none stated",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "None stated"
    }
  ],
  "next": "/api/comparisons/v1?page=23",
  "request_id": "c3DGe01EydjOMbzF"
}